Activation-induced apoptosis of peripheral lymphocytes treated with 7-hydroxystaurosporine, UCN-01

Investigational New Drugs

Volumn 17, Issue 4, 1999, Pages 335-341

  Fukumoto, Hisao ^a   Tamura, Tomohide ^b   Kamiya, Yoshikazu ^a   Usuda, Jitsuo ^a   Suzuki, Toshihiro ^a   Kanzawa, Fumihiko ^a   Kuh, Hyo Jeong ^a   Ohe, Yuichiro ^c   Saijo, Nagahiro ^b   Nishio, Kazuto ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Apoptosis; Fas; Fas ligand; IL 2 receptor; UCN 01

Indexed keywords

7 HYDROXYSTAUROSPORINE; FAS ANTIGEN; INTERLEUKIN 2 RECEPTOR; LIPOCORTIN 5; PROTEIN KINASE C INHIBITOR;

APOPTOSIS; ARTICLE; CELL VIABILITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; NORMAL HUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

ALKALOIDS; ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; RECEPTORS, INTERLEUKIN-2; STAUROSPORINE; TIME FACTORS;

EID: 0033509995     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006374118879     Document Type: Article

References (23)

1. Takahashi I, Kobayashi E, Asano K, Yoshida M, Nakano H; UCN-01, a selective inhibitor of protein kinase C from streptomyces. J Antibiot 40: 1782-1784, 1987
2. Takahashi I, Nakanishi S, Kobayashi E, Nakano H, Suzuki K, Tamaoki T: Hypericin and pseudohypericin specifically inhibit protein kinase C: possible relation to their antiretroviral activity. Biochem Biophys Res Commun 165: 1207-1212, 1989
3. Akiyama T, Yoshida T, Tsujita T, Shimizu M, Mizukami T, Okabe M, Akinaga S: G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells. Cancer Res 57: 1495-1501, 1997
4. Wang Q, Worland PJ, Clark JL, Carlson BA, Sausville EA: Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinases 1 and 2. Cell Growth Different 6: 927-936, 1995
5. Kawakami K, Futami H, Takahara J, Yamaguchi K: UCN-01, 7-hydroxylstaurosporine, inhibits kinase activity of cyclin-dependent kinases and reduces the phosphorylation of the retinoblastoma susceptibility gene product in A549 human lung cancer cell line. Biochem Biophys Res Commun 219: 778-783, 1996
6. Byrd JC, Rai KR, Sausville EA, Grever MR: Old and new therapies in chronic lymphocytic leukemia: now is the time for a reassessment of therapeutic goals. Sem Oncol 25: 65-74, 1998
7. Fuse E, Tanii H, Kurata N, Kobayashi H, Shimada Y, Tamura T, Sasaki Y, Tanigawara Y, Lush RD, Headlee D, Figg WD, Arbuck SG, Senderowicz AM, Sausville EA, Akinaga S, Kuwabara T, Kobayashi S: Unpredicted clinical pharmacology of UCN-01 caused by specific binding to human alphal-acid glycoprotein. Cancer Res 58: 3248-3253, 1998
8. Tice RR, Strauss GH, Peters WP: High-dose combination alkylating agents with autologous bone-marrow support in patients with breast cancer: preliminary assessment of DNA damage in individual peripheral blood lymphocytes using the single cell gel electrophoresis assay. Mut Res 271: 101-113, 1992
9. Gallardo S, Cardaba B, del Pozo V, de Andres B, Cortegano I, Jurado A, Tramon P, Palomino P, Lahoz C: Study of apoptosis in human lymphocytes by toxic substances implicated in toxic oil syndrome. Toxicology 118: 71-82, 1997
10. Snyder CA, Valle CD: Lymphocyte proliferation assays as potential biomarkers for toxicant exposures. J Toxicol Env Health 34: 127-139, 1991
11. Leonard WJ, Depper JM, Robb RJ, Waldmann TA, Greene WC: Characterization of the human receptor for T-cell growth factor. Proc Nat Acad Sci USA 80: 6957-6961, 1983
12. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H et al.: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66: 848-858, 1985
13. Uchiyama T, Broder S, Waldmann TA: A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J Immunol 126: 1393-1397, 1981
14. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243, 1991
15. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169: 1747-1756, 1989
16. Kobayashi N, Hamamoto Y, Yamamoto N, Ishii A, Yonehara M, Yonehara S: Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc Nat Acad Sci USA 87: 9620-9624, 1990
17. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317, 1992
18. Fukumoto H, Nishio K, Ohta S, Hanai N, Saijo N: Reversal of adriamycin resistance with chimeric anti-ganglioside GM2 antibody. Int J Cancer 67; 676-680, 1996
19. Nozawa K, Kayagaki N, Tokano Y, Yagita H, Okumura K, Hasimoto H: Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases. Arthr Rheumat 40: 1126-1129, 1997
20. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatake K, Drummond AH, Nagata S: Fas ligand in human serum. Nat Med 2: 317-322, 1996
21. Nagata S, Golstein P: The Fas death factor. Science 267: 1449-1456, 1995
22. Tanaka M, Suda T, Takahashi T, Nagata S: Expression of the functional soluble form of human fas ligand in activated lymphocytes, EMBO J 14: 1129-1135, 1995
23. Proust JJ, Kittur DS, Buchholz MA, Nordin AA: Restricted expression of mitogen-induced high affinity IL-2 receptors in aging mice. J Immunol 141: 4209-4216, 1988